Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer

被引：0
|
作者：
Tatsuya Miyazaki
Hitoshi Ojima
Minoru Fukuchi
Makoto Sakai
Makoto Sohda
Naritaka Tanaka
Shigemasa Suzuki
Keisuke Ieta
Kana Saito
Akihiko Sano
Takehiko Yokobori
Takanori Inose
Masanobu Nakajima
Hiroyuki Kato
Hiroyuki Kuwano
机构：
[1] Gunma University Graduate School,Department of General Surgical Science (Surgery 1)
[2] Gunma Prefectural Cancer Center,Department of Gastroenterological Surgery
[3] Gunma Chuo Hospital,Department of Surgery
[4] Isesaki Municipal Hospital,Department of Surgery
[5] Dokkyo Medical University,Department of Surgery I
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Docetaxel; Esophageal Cancer; Acute Kidney Injury; CDDP; Complete Response Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3653 / 3658
页数：5
相关论文
共 50 条
  • [21] Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Kim, Sung Rok
    Park, Sung-En
    Yuh, Young Jin
    Sohn, Byeong Seok
    Lee, Hye Ran
    Song, Hong-Suk
    Lee, Kyung-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer
    Shiraishi, Osamu
    Yamasaki, Makoto
    Makino, Tomoki
    Motoori, Masaaki
    Miyata, Hiroshi
    Shinkai, Masayuki
    Kimura, Yutaka
    Hirao, Motohiro
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kobayashi, Kenji
    Yano, Masahiko
    Doki, Yuichiro
    Yasuda, Takushi
    ONCOLOGY, 2017, 92 (02) : 101 - 108
  • [23] Phase II study of docetaxel, cisplatin, and 5-fluorouracil (TPF) as first-line chemotherapy in advanced gastric cancer
    Chowdhury, Q.
    Hossain, S.
    Reza, S.
    Hai, M. A.
    Faruqui, M.
    Morshed, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy
    Asaka, Shinichi
    Shimakawa, Takeshi
    Yamaguchi, Kentaro
    Murayama, Minoru
    Shimazaki, Asako
    Katsube, Takao
    Naritaka, Yoshihiko
    ANTICANCER RESEARCH, 2016, 36 (11) : 6165 - 6171
  • [25] Phase II Study of Combined Chemotherapy with Docetaxel, CDDP and 5-FU for Highly Advanced Esophageal Cancer
    Osaka, Yoshiaki
    Shinohara, Motoo
    Hoshino, Sumito
    Ogata, Takashi
    Takagi, Yu
    Tsuchida, Akihiko
    Aoki, Tatsuya
    ANTICANCER RESEARCH, 2011, 31 (02) : 633 - 638
  • [26] Phase II study of chemoselection with docetaxel plus 5-fluorouracil and cisplatin induction chemotherapy and subsequent conversion surgery for locally advanced unresectable esophageal cancer
    Yokota, Tomoya
    Kato, Ken
    Hamamoto, Yasuo
    Tsubosa, Yasuhiro
    Ogawa, Hirofumi
    Ito, Yoshinori
    Hara, Hiroki
    Ura, Takashi
    Kojima, Takashi
    Chin, Keisho
    Hironaka, Shuichi
    Kii, Takayuki
    Kojima, Yasushi
    Akutsu, Yasunori
    Matsushita, Hisayuki
    Kawakami, Kentaro
    Mori, Keita
    Nagai, Yushi
    Asami, Chika
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
    A Roy
    D Cunningham
    R Hawkins
    H Sörbye
    A Adenis
    J-R Barcelo
    G Lopez-Vivanco
    G Adler
    J-L Canon
    F Lofts
    C Castanon
    E Fonseca
    O Rixe
    J Aparicio
    J Cassinello
    M Nicolson
    M Mousseau
    A Schalhorn
    L D'Hondt
    J Kerger
    D K Hossfeld
    C Garcia Giron
    R Rodriguez
    P Schoffski
    J-L Misset
    British Journal of Cancer, 2012, 107 : 435 - 441
  • [28] Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
    Roy, A.
    Cunningham, D.
    Hawkins, R.
    Sorbye, H.
    Adenis, A.
    Barcelo, J-R
    Lopez-Vivanco, G.
    Adler, G.
    Canon, J-L
    Lofts, F.
    Castanon, C.
    Fonseca, E.
    Rixe, O.
    Aparicio, J.
    Cassinello, J.
    Nicolson, M.
    Mousseau, M.
    Schalhorn, A.
    D'Hondt, L.
    Kerger, J.
    Hossfeld, D. K.
    Giron, C. Garcia
    Rodriguez, R.
    Schoffski, P.
    Misset, J-L
    BRITISH JOURNAL OF CANCER, 2012, 107 (03) : 435 - 441
  • [29] Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
    Yoshihiro Tanaka
    Kazuhiro Yoshida
    Atsuko Yamada
    Toshiyuki Tanahashi
    Naoki Okumura
    Nobuhisa Matsuhashi
    Kazuya Yamaguchi
    Tatsuhiko Miyazaki
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1153 - 1155
  • [30] Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: Results of a phase II study
    Constenla M.
    Garcia-Arroyo R.
    Lorenzo I.
    Carrete N.
    Campos B.
    Palacios P.
    Gastric Cancer, 2002, 5 (3) : 142 - 147
12345